Stock CMH CHORDATE MEDICAL HOLDING AB
Add to a list
To use this feature you must be a member
Log inSign up

Chordate Medical Holding AB Share Price

Equities

CMH

SE0009495559

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm
Other stock markets
 16:29:46 03/05/2024 BST 		5-day change 1st Jan Change
0.061 SEK -3.79% Intraday chart for Chordate Medical Holding AB +9.32% -61.97%
03-22 Chordate Medical Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
03-22 Chordate Medical Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI

Financials

Sales 2022 109K 10.03K 800K Sales 2023 1.75M 162K 12.87M Capitalization 37.28M 3.45M 275M
Net income 2022 -27M -2.5M -199M Net income 2023 -29M -2.68M -214M EV / Sales 2022 723 x
Net cash position 2022 3.68M 340K 27.09M Net cash position 2023 8.46M 782K 62.3M EV / Sales 2023 16.5 x
P/E ratio 2022
-2.89 x
P/E ratio 2023
-1.23 x
Employees 3
Yield 2022 *
-
Yield 2023
-
Free-Float 36.96%
More Fundamentals * Assessed data

Chart Chordate Medical Holding AB

Dynamic Chart

Latest news about Chordate Medical Holding AB

Chordate Medical Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Chordate Medical Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Chordate Medical Gains EU Patent for Chronic Migraine Treatment MT
Chordate Medical Holding AB Announces the European Patent Office Grants New Patent CI
Chordate Medical Holding AB Signs Agreement with German Clinic for the Ozilia Treatment for Chronic Migraine CI
Chordate Medical Completes Training of Clinic Staff and Assists in Initiation of Treatment for First Three Patients at the Private Clinic in Hamburg CI
Chordate Medical Holding AB Announces First Patients Included in the Post-Market Study PM010 CI
Chordate Medical Holding AB Announces First Patient Included in the Company's Open Pilot Study PM009 CI
Chordate Medical Holding AB Receives First Installation of the Ozilia Migraine Treatment at a Private Clinic in Hamburg CI
Chordate Medical Holding AB Announces Post-Market Study of Chordate's Ozilia® Migraine Treatment Has Commenced in Four Different Markets CI
Chordate Medical Holding AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Chordate Medical Trademarks Migraine Treatment Ozilia in EU MT
Chordate Medical Receives Registration of the Tradark Ozilia CI
Chordate Medical Holding AB Introduces New Trademark for Migraine Treatment: Ozilia? - Migraine Relief CI
Chordate Medical Holding AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
More news

Press releases Chordate Medical Holding AB

Chordate will be granted a fourth patent in the USA AQ
Chordate's board member to BioStock: "Women's health is a concern for society at large" AQ
Chordate presents Ozilia at LSX World Congress on April 29-30 AQ
Chordate presents Ozilia to national specialist associations from Germany, Switzerland, & Austria AQ
Chordate presents at the Feminvest investor conference in Oslo AQ
More press releases

Quotes and Performance

1 day-3.79%
1 week+9.32%
Current month+0.66%
1 month-3.48%
3 months-48.74%
6 months-72.27%
Current year-61.97%
More quotes

Highs and lows

1 week
0.05
Extreme 0.0532
0.07
1 month
0.05
Extreme 0.051
0.07
Current year
0.05
Extreme 0.048
0.24
1 year
0.05
Extreme 0.048
0.50
3 years
0.05
Extreme 0.048
5.56
5 years
0.05
Extreme 0.048
5.56
10 years
0.05
Extreme 0.048
14.00
More quotes

Managers and Directors - Chordate Medical Holding AB

Managers TitleAgeSince
Anders Henrik Weilandt CEO
 Chief Executive Officer 63 31/10/14
Niklas Lindecrantz DFI
 Director of Finance/CFO 56 01/10/17
Jan Hermansson CTO
 Chief Tech/Sci/R&D Officer 68 31/12/11
Members of the board TitleAgeSince
Jan Tommy Lennart Hedberg BRD
 Director/Board Member 69 31/05/14
Gunilla Lundmark BRD
 Director/Board Member 61 31/03/17
Anders Henrik Weilandt CEO
 Chief Executive Officer 63 31/10/14
More insiders

Quotes

Date Price Change Volume
03/05/24 0.061 -3.79% 1,123,719
02/05/24 0.0634 +4.62% 1,328,945
30/04/24 0.0606 +6.32% 333,040
29/04/24 0.057 +2.15% 446,892
26/04/24 0.0558 -2.79% 1,084,519

Delayed Quote Nasdaq Stockholm, May 03, 2024 at 04:29 pm

More quotes

Company Profile

Chordate Medical Holding AB (publ) is a medical technology company based in Sweden. The Company develops treatment method through nerve stimulation for chronic nasal congestion. The Company’s headquartered is located in Kista, Sweden.
Sector
Advanced Medical Equipment & Technology
Calendar
16/05/2024 - Annual General Meeting
More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
CHORDATE MEDICAL HOLDING AB Stock Chordate Medical Holding AB
-61.97% 2.76M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+7.84% 218B
DANAHER CORPORATION Stock Danaher Corporation
+7.35% 184B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+13.04% 135B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
-1.33% 62.38B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+11.80% 51.37B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+4.81% 50.9B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
+0.30% 40.87B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+2.78% 36.28B
RESMED, INC. Stock ResMed, Inc.
+26.14% 31.88B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. CMH Stock